The additive effects of nicotinamide mononucleotide and melatonin on mitochondrial biogenesis and fission/fusion, autophagy, and microRNA-499 in the aged rat heart with reperfusion injury

Naunyn Schmiedebergs Arch Pharmacol. 2023 Aug;396(8):1701-1711. doi: 10.1007/s00210-023-02383-y. Epub 2023 Feb 18.

Abstract

The prognosis of myocardial ischemia/reperfusion (I/R) injury is poor in elderly patients. Aging increases the susceptibility of the heart to cell death from I/R injury and prevents the optimal effectiveness of cardioprotective modalities. Since the interaction of aging with cardioprotection is multifactorial, combination therapy may overcome the above-mentioned burden through correcting various components of the injury. Here, we explored the effects of nicotinamide mononucleotide (NMN)/melatonin combination therapy on mitochondrial biogenesis and fission/fusion, autophagy, and microRNA-499 in the aged rat heart with reperfusion injury. Ex vivo model of myocardial I/R injury was established by coronary occlusion and re-opening in 30 aged male Wistar rats (400-450 g, 22-24 months old). NMN (100 mg/kg/48 h, intraperitoneally) was administered over 28 days before I/R, and melatonin (50 µM) was added to the perfusion solution at early reperfusion. CK-MB release and expression of mitochondrial biogenesis genes and proteins, mitochondrial fission/fusion proteins, autophagy genes, and microRNA-499 were assessed. NMN/melatonin combination therapy concomitantly decreased CK-MB release in aged reperfused hearts (P < .001). It also upregulated SIRT1/PGC-1α/Nrf1/TFAM profiles at both gene and protein levels, Mfn2 protein, and microRNA-499 expression, and downregulated Drp1 protein and Beclin1, LC3, and p62 genes (P < .05 to P < .001). The effect of combination therapy was greater than individual ones. Co-application of NMN/melatonin within the setting of I/R injury in the aged rat heart induced noticeable cardioprotection through modulation of a coordinated network including microRNA-499 expression along with mitochondrial biogenesis associated with SIRT1/PGC-1α/Nrf1/TFAM profiles, mitochondrial fission/fusion, and autophagy, therefore, appears to prevent the burden of myocardial I/R injury in elderly patients.

Keywords: Aging; Autophagy; Cardioprotection; Melatonin; MicroRNA-499; Mitochondrial biogenesis; Mitochondrial dynamics; Myocardial reperfusion injury; Nicotinamide mononucleotide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy
  • Male
  • Melatonin* / pharmacology
  • Melatonin* / therapeutic use
  • MicroRNAs* / genetics
  • Myocardial Reperfusion Injury* / drug therapy
  • Myocardial Reperfusion Injury* / genetics
  • Myocardial Reperfusion Injury* / prevention & control
  • Nicotinamide Mononucleotide / pharmacology
  • Nicotinamide Mononucleotide / therapeutic use
  • Organelle Biogenesis
  • Rats
  • Rats, Wistar
  • Reperfusion Injury*
  • Sirtuin 1 / genetics
  • Sirtuin 1 / metabolism

Substances

  • Melatonin
  • Nicotinamide Mononucleotide
  • Sirtuin 1
  • MicroRNAs
  • MIRN499 microRNA, rat